A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 103.04
GOOG 572.39
MSFT 45.05
BAC 16.11
FB 74.85

Recently Added

UNP 105.82
SIAF 0.41
VOIL 1.19
UDHI 0.04
REVI 0.02

Gaining Speed

APDN 0.11
MRIB 0.01
RUTH 11.20
SOPW 0.72
UNP 105.82

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!